TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Jucker Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 1,552 | 1,462 | 2,898 |
Financial expenses | 686 | 204 | 290 |
Earnings before taxes | -880 | 53 | 814 |
EBITDA | -350 | 154 | 1,031 |
Total assets | 6,416 | 4,475 | 4,788 |
Current assets | 6,374 | 4,433 | 4,746 |
Current liabilities | 5,114 | 2,293 | 2,648 |
Equity capital | 1,302 | 2,182 | 2,140 |
- share capital | 100 | 100 | 100 |
Employees (average) | 2 | 3 | 4 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 20.3% | 48.8% | 44.7% |
Turnover per employee | 776 | 487 | 724 |
Profit as a percentage of turnover | -56.7% | 3.6% | 28.1% |
Return on assets (ROA) | -3.0% | 5.7% | 23.1% |
Current ratio | 124.6% | 193.3% | 179.2% |
Return on equity (ROE) | -67.6% | 2.4% | 38.0% |
Change turnover | 90 | -1,436 | -173 |
Change turnover % | 6% | -50% | -6% |
Chg. No. of employees | -1 | -1 | 0 |
Chg. No. of employees % | -33% | -25% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.